Navigation Links
Pharma IQ Presents the Latest Trends in Clinical Trial Supply
Date:6/19/2013

NEW YORK, June 19, 2013 /PRNewswire/ --

Pharma IQ is pleased to announce the release of a brand new infographic summary of the results from an industry survey conducted earlier this year.

Nearly a third of all respondents stated that CROs would be an area of active investment in the next 6 months. 50% of respondents will be running 6 or more clinical trials in the BRIC region. The infographic, created in association with the Clinical Trial Supply USA Summit explores the latest trends, challenges and opportunities in clinical trial supply and is available to access free of charge. Download the infographic online at http://www.clinicalsupplyusa.com/News.

The Clinical Trial Supply USA Summit, taking place in Boston in September, is a unique event focusing on how to achieve flexibility, cut costs and streamline your organization's clinical supply. The Summit also brings the latest in European regulatory insight to the states.

Industry experts speaking at the event include;

Buz Hillman, Associate Director, Clinical Supply Systems, Johnson and Johnson; Mary Foster, Chair, Packaging and Storage Expert Committee, United States Pharmacopeia; Riekert Bruinick, Senior GMP/GDP Inspector, Dutch Healthcare Inspectorate; John Griffen, Global Clinical Supplies, ENVIVO Pharma; Lindsay Pinnick, Global Supply Coordinator, UCB Pharma; Ronald Wong, Clinical Pharmacist, Genzyme; '/>"/>

SOURCE Pharma IQ
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... DALLAS , Sept. 19, 2014 /PRNewswire-iReach/ ... Chinese Oxybutynin Hydrochloride Industry, 2009-2019 is a ... and Chinese Oxybutynin Hydrochloride industry. The report ... Hydrochloride including its classification, application and manufacturing ... China,s top manufacturers of Oxybutynin Hydrochloride listing ...
(Date:9/19/2014)... , September 19, 2014 ... ) has announced the addition of the ... report to their offering.      ... have been broadly classified into wide categories ... used for the treatment of different gynecological ...
(Date:9/19/2014)... , September 19, 2014 ... by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, ... (Hospitals), Advanced technologies - Global Forecast to 2019" ... poised to reach $19,786.3 Million by 2019 from ... 6.8% from 2014 to 2019. Browse ...
Breaking Medicine Technology:Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4
... 17, 2011 Reportlinker.com announces that a ... its catalogue: Product ... Pipeline Strengthening the In-Vitro Diagnostics and Cardiovascular ... http://www.reportlinker.com/p0397058/Product-Pipeline-in-Medical-Equipment-Market---Robust-Pipeline-Strengthening-the-In-Vitro-Diagnostics-and-Cardiovascular-Devices-Market.html Product Pipeline in ...
... Ala., Feb. 17, 2011 SuccessEHS, a nationally recognized, ... EMR) software vendor, was recently named by the Arkansas ... in accordance with government health care initiatives. ... Arkansas REC are endowed by the Office of ...
Cached Medicine Technology:Reportlinker Adds Product Pipeline in Medical Equipment Market - Robust Pipeline Strengthening the In-Vitro Diagnostics and Cardiovascular Devices Market 2Arkansas REC Selects SuccessEHS as Preferred Vendor 2Arkansas REC Selects SuccessEHS as Preferred Vendor 3
(Date:9/22/2014)... A novel study by the Cancer Science Institute ... of Singapore (NUS) found that an increase in ... that are directly implicated in acute myelogenous leukaemia ... Led by Associate Professor Chng Wee Joo, Deputy ... and Director of the National University Cancer Institute, ...
(Date:9/22/2014)... Thousand Oaks dentist , Dr. Sharon ... Invisalign is a type of orthodontic treatment that can ... can vary based on the extent of the dental ... needed. During this promotion, Dr. Shamoiel is offering complete ... of the adult population has an unhealthy bite, and ...
(Date:9/22/2014)... HealthDay Reporter FRIDAY, Sept. 19, ... with type 2 diabetes found that intensively lowering blood ... strokes and deaths. But intensive blood sugar control didn,t ... study, investigators followed nearly 8,500 participants of a completed ... and blood sugar levels strictly controlled, while others had ...
(Date:9/22/2014)... Oklahoma (PRWEB) September 22, 2014 ... of thought which advocates addiction as a disease ... disease; one with the addicted person being chronically ... experience long periods of sobriety. , Narconon ... Oklahoma, delivers a non-traditional and holistic approach to ...
(Date:9/22/2014)... The Little Gym of Houston , ... charitable organization based in Nashville, Tennessee that provides shoes to ... A pair of shoes can, seriously, change the entire life ... feet. Confidence, comfort, and health are all improved when a ... to play, grown, and live. Aside from the good feeling ...
Breaking Medicine News(10 mins):Health News:Singapore researchers discover a gene that increases incidence of AML 2Health News:Thousand Oaks Cosmetic Dentist, Sharon Shamoiel DDS, Is Now Offering a Special on Invisalign 2Health News:Tight Blood Sugar Control Doesn't Prevent Strokes in Diabetics: Study 2Health News:Tight Blood Sugar Control Doesn't Prevent Strokes in Diabetics: Study 3Health News:Narconon Arrowhead Offers Information on Disease Theory of Addiction in New Release of Booklet 2Health News:Narconon Arrowhead Offers Information on Disease Theory of Addiction in New Release of Booklet 3Health News:The Little Gym of Houston and Stride Rite Partner to Support Soles4Souls 2
... Berger & Grossmann LLP is issuing the following statement regarding the Sunrise Senior Living, Inc. Securities Litigation. , , ... UNITED STATES DISTRICT COURT, ... INC. Master File, SECURITIES LITIGATION ... Relates to: All Cases, ...
... suggests, , , MONDAY, April 20 (HealthDay News) -- Want to live ... manage your stress. , A new study found that those were ... 100, and longevity is thought to run in families. , "We ... set the children of centenarians apart from other people the same ...
... HOLLYWOOD, Calif., April 20 IPC The Hospitalist ... hospitalist physician group practice company, announced today that it will ... on May 4, 2009, after the market close.A conference call ... (2:00 p.m. PT) on May 4, 2009 and will be ...
... "With Hurricanes Katrina, Rita and Ike we ... and healthcare providers navigate through chaos created by ... Davies, M.D., a seasoned critical care physician and ... which enable communication between patients, their physicians, hospitals ...
... with Picoplatin as Second-Line Therapy for Small Cell Lung ... Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a ... of its Phase 2 clinical trial of picoplatin in ... were published in the April 20, 2009, print ...
... 20, 2009 Forest Laboratories, Inc. (NYSE: FRX ... announced today that Savella(TM) (milnacipran HCl), a selective serotonin and ... will be shipped to wholesalers on April 24th and will ... Savella was approved by the U.S. Food and Drug Administration ...
Cached Medicine News:Health News:All Persons Who Purchased or Acquired the Common Stock of Sunrise Senior Living, Inc. ('Sunrise') Between February 26, 2004 and July 28, 2006, Inclusive, and Were Damaged Thereby (The 'Class') 2Health News:All Persons Who Purchased or Acquired the Common Stock of Sunrise Senior Living, Inc. ('Sunrise') Between February 26, 2004 and July 28, 2006, Inclusive, and Were Damaged Thereby (The 'Class') 3Health News:Outgoing Nature Could Get You to 100 2Health News:Outgoing Nature Could Get You to 100 3Health News:IPC The Hospitalist Company, Inc. to Report First Quarter 2009 Financial Results 2Health News:PatientCentral Technologies, LLC and VerdaSee Solutions, Inc. Team Up With Congressional Staff in Washington, DC for Disaster Preparedness 2Health News:PatientCentral Technologies, LLC and VerdaSee Solutions, Inc. Team Up With Congressional Staff in Washington, DC for Disaster Preparedness 3Health News:PatientCentral Technologies, LLC and VerdaSee Solutions, Inc. Team Up With Congressional Staff in Washington, DC for Disaster Preparedness 4Health News:Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology 2Health News:Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology 3Health News:Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology 4Health News:Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology 5Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM) 2Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM) 3Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM) 4Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM) 5Health News:Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM) 6
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: